U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07195708) titled 'Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')' on Sept. 25.
Brief Summary: To demonstrate the safety and efficacy of Orbera365 in obese populations to support the registration of Orbera365.
Study Start Date: April 30, 2026
Study Type: INTERVENTIONAL
Condition:
Weight Loss
Intervention:
DEVICE: Treatment group
The treatment group was the group with the placement of Orbera 365 plus lifestyle management
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Boston Scientific Corporation
Published by HT Digital Content Services with permission from Health Daily Digest....